Business

December 2, 2013 10:02 AM

BioDelivery Sciences gets good news from FDA

BioDelivery Sciences International announced Monday that it expects to begin Phase 3 clinical trials for its drug Clonidine by the first quarter of next year.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs